Wilmington, Delaware, United States, Aug. 11, 2023 (GLOBE NEWSWIRE) -- The global acute kidney injury treatment market is projected to flourish at a CAGR of 7.5% from 2022 to 2031. As per the report published by TMR, a valuation of US$ 3.0 billion is anticipated for the market in 2031. As of 2023, the market for acute kidney injury treatment is expected to close at US$1.7 billion.
The increasing incidence of acute kidney injury due to factors like aging populations, chronic diseases, and surgeries is driving the demand for effective treatments.
Download Sample Copy with Graphs & List of Figures@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=67523
An increase in the geriatric population leads to a high rate of ailments. This, in turn, is likely to augment the demand for acute kidney injury medications across the globe in the near future. The growing improvement in healthcare infrastructure, favorable reimbursement policies, and advancements in healthcare facilities
The growing technological advancements in healthcare infrastructure and favorable government policies are also improving the adoption of advanced acute kidney injury equipment and diagnostic treatment, leading to increased market demand.
Key Takeaways from the Market Study
- As of 2022, the acute kidney injury treatment market was valued at US$ 1.6 billion
- By type, pre-renal acute kidney injury segment to enjoy high demand, accumulating a high revenue share during the forecast period
- Based on treatment, the dialysis segment accounts for the highest market share, owing to the increased number of dialysis centers across the globe.
- Based on end-user, the hospital segment is expected to generate high revenue during the forecast period, due to the easy availability of diagnostic equipment in hospitals.
Expand Operations in the Future – To Get Requisite Details, Ask For a Custom Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=67523
Acute Kidney Injury Treatment: Key Trends and Opportunistic Frontiers
- The growing expansion of the healthcare industry and the adoption of automated diagnostic equipment contribute to the growth of the acute kidney injury treatment market.
- The rising disposable income and growing health consciousness have enabled patients to opt for advanced treatment for these diseases. The increasing awareness regarding the treatment for acute kidney disease is expected to boost the sales of AKI treatment contributing to the growth of the market
- Increased healthcare spending and improved healthcare infrastructure in various regions have contributed to the adoption of advanced acute kidney injury treatments.
- Growing awareness among patients and healthcare professionals about the consequences of acute kidney injury and the need for timely treatment is fostering market growth.
Acute Kidney Injury Treatment Market- Regional Analysis
- North America holds a significant share in the acute kidney injury treatment market due to advanced healthcare infrastructure, increased awareness about acute kidney injury, and the presence of key market players. The region's emphasis on early diagnosis and the adoption of innovative treatment modalities contribute to market growth.
- Asia-Pacific region is witnessing rapid market growth due to a rising prevalence of risk factors for acute kidney injury, such as diabetes and hypertension, in countries like India and China. Increasing healthcare investments, improving access to medical facilities, and rising awareness about acute kidney injury are driving the market in this region.
Competitive Landscape
The acute kidney injury treatment market is highly consolidated, with the presence of a small number of dominant players. The leading players in the acute kidney injury treatment market are investing in new product development, mergers, and acquisitions to gain a competitive edge. Transparency Market Research has profiled the following players in its global acute kidney injury treatment market report:
- Angion Biomedica Corp.
- AM-Pharma
- Quark Pharmaceuticals, Inc.
- Baxter International, Inc.
- Fresenius Medical Care AG & Co. KGaA.
- B. Braun Melsungen AG
- Asahi Kasei Medical Co., Ltd.
- LG Chem
Key Developments in the Acute Kidney Injury Treatment Market
- Baxter has been focusing on developing innovative renal care solutions, including therapies for AKI. The company has collaborated with various healthcare organizations to expand access to renal care and educate healthcare professionals about AKI management.
- Medtronic has been exploring innovative approaches to AKI treatment, including the use of technology and devices. The company is involved in clinical trials and research projects to evaluate new treatment strategies.
- In March 2021, To develop a suite of prognostic tools to improve the detection of drug-induced kidney injury C-Path announced the launch of an acute kidney injury project in partnership with the USA Food and Drug Administration (FDA) for Drug Evaluation and Research, the Office of translational science, and the Division of cardiology and Nephrology.
Accelerate Your Growth. Get Your Copy of this Premium Research Report Now!
Acute Kidney Injury Treatment Market – Key Segments
Treatment
- Dialysis
- Supportive Care
Type
- Pre-renal Acute Kidney Injury
- Intrinsic Renal Acute Kidney Injury
- Post-renal Acute Kidney Injury
End-user
- Hospitals
- Ambulatory Surgical Centers
- Others
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
Contact:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
